m+Medelevator.RU
← Поиск публикаций
Nature biomedical engineering · 2025

Multiparametric cellular and spatial organization in cancer tissue lesions with a streamlined pipeline.

СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Buckup Mark, Figueiredo Igor, Ioannou Giorgio, Ozbey Sinem, Cabal Rafael, Tabachnikova Alexandra, Troncoso Leanna, Le Berichel Jessica, Zhao Zhen, Ward Stephen C, Hennequin Clotilde, Akturk Guray, Hamel Steve, Fiel Maria Isabel, Brody Rachel, Schwartz Myron, Marron Thomas U, Kim-Schulze Seunghee, Roudko Vladimir, Gonzalez-Kozlova Edgar, Hamon Pauline, Merad Miriam, Gnjatic Sacha

Аннотация

Multiplex immunostaining analysis remains fragmented, underperforming and labour intensive despite tissue proteomic methodologies achieving ever-increasing marker complexity. Here we propose an open-source, user-guided automated pipeline that streamlines start-to-finish, single-cell resolution analysis of whole-slide tissue, named multiplex-imaging analysis, registration, quantification and overlaying (MARQO). MARQO integrates elastic image registration, iterative nuclear segmentation, unsupervised clustering with mini-batch k-means and user-guided cell classification through a graphical interface. We compare and validate MARQO using multiplexed immunohistochemical consecutive staining on a single slide using human tumour and adjacent normal tissue samples. Performance is compared with manually curated pathologist determinations and quantification of multiple markers. We optimize MARQO to analyse diverse tissue sizes from whole tissue, biopsy, and tissue microarray and staining approaches, such as singleplex immunohistochemistry and 20-colour multiplex immunofluorescence, to determine marker co-expression patterns in multiple human solid cancer types. Lastly, we validate CD8+ T cell enrichment in hepatocellular carcinoma responders to neoadjuvant cemiplimab in a phase 2 clinical trial, further showing the ability of MARQO to identify spatially resolved in situ mechanisms by providing multiplex whole-slide single-cell resolution data.

Предметные рубрики MeSH

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты